| Literature DB >> 27589723 |
Huiling Geng1,2, Xinchi Yu3, Ailin Lu4, Haoqiang Cao5, Bohang Zhou6, Le Zhou7, Zhong Zhao8.
Abstract
The essential oil from the powder residual of dried bitter almond, a novel and environmentally-friendly fungicide, was successfully extracted in a 0.7% yield by hydro-distillation under optimized conditions. The chemical composition of bitter almond essential oil (BAEO) was analyzed by gas chromatography-mass spectrometry (GC-MS). Twenty-one different components representing 99.90% of the total essential oil were identified, of which benzaldehyde (62.52%), benzoic acid (14.80%), and hexadecane (3.97%) were the most abundant components. Furthermore, the in vitro and in vivo antifungal activities of BAEO against common plant pathogenic fungi were evaluated by the mycelium linear growth rate method and pot test, respectively. It was documented that 1 mg/mL of BAEO could variously inhibit all tested pathogenic fungi with the inhibition rates of 44.8%~100%. Among the tested 19 strains of fungi, the median effective concentration (EC50) values of BAEO against Alternaria brassicae and Alternaria solani were only 50.2 and 103.2 μg/mL, respectively, which were higher than those of other fungi. The in vivo antifungal activity of BAEO against Gloeosporium orbiculare was much higher than Blumeria graminis. The protective efficacy for the former was up to 98.07% at 10 mg/mL and the treatment efficacy was 93.41% at 12 mg/mL. The above results indicated that BAEO has the great potential to be developed as a botanical and agricultural fungicide.Entities:
Keywords: GC-MS; antifungal activity; bitter almond; chemical composition; essential oil
Mesh:
Substances:
Year: 2016 PMID: 27589723 PMCID: PMC5037700 DOI: 10.3390/ijms17091421
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Hydrolysis of amygdalin.
Identification of the chemical composition of bitter almond essential oil (BAEO) by chromatography–mass spectrometry (GC–MS).
| Compound | TR (min) a | Formula | CAS Number | Relative Content (%) b | SI (min) c |
|---|---|---|---|---|---|
| ethylbenzene | 4.495 | C8H10 | 100-41-4 | 0.69 | 93 |
| 1,2-xylene | 4.560 | C8H10 | 95-47-6 | 0.18 | 89 |
| 1,3-xylene | 4.720 | C8H10 | 108-38-3 | 1.56 | 95 |
| 2-methylundecane | 4.865 | C12H26 | 7045-71-8 | 0.26 | 92 |
| tetradecane | 5.040 | C14H30 | 629-59-4 | 0.61 | 93 |
| 1,4-xylene | 5.405 | C8H10 | 106-42-3 | 0.90 | 95 |
| dodecane | 5.585 | C12H36 | 112-40-3 | 1.50 | 95 |
| 1-ethyl-3-methyl-benzene | 6.145 | C9H12 | 620-14-4 | 1.61 | 84 |
| hexadecane | 6.345 | C16H34 | 544-76-3 | 3.97 | 94 |
| mesitylene | 7.275 | C9H12 | 108-67-8 | 1.62 | 94 |
| 1,2,4-trimethylbenzene | 7.320 | C9H12 | 95-63-6 | 0.23 | 88 |
| eicosane | 10.600 | C20H42 | 112-95-8 | 2.26 | 94 |
| heptadecane | 10.705 | C17H36 | 629-78-7 | 0.39 | 94 |
| benzaldehyde | 11.955 | C7H6O | 100-52-7 | 62.52 | 98 |
| dodecyl aldehyde | 14.730 | C12H24O | 112-54-9 | 1.18 | 92 |
| 3-(hydroxy-phenyl-methyl)-2,3-dimethyl-octan-4-one | 16.025 | C17H26O2 | 911800-56-1 | 1.23 | 84 |
| benzyl alcohol | 16.865 | C7H8O | 100-51-6 | 1.59 | 87 |
| benzyl cyanide | 17.505 | C8H7N | 140-29-4 | 1.06 | 92 |
| 3-ethyl-2-undecanone | 19.995 | C13H26O | 328078-05-3 | 0.50 | 83 |
| 3,5-di- | 21.335 | C14H22O | 1138-52-9 | 1.24 | 82 |
| benzoic acid | 22.835 | C7H6O2 | 65-85-0 | 14.80 | 94 |
a TR, retention time listed in the GC–MS spectra; b Percentage of peak area from the MS signal; c SI, similarity of the structure between the identified compound and the real one.
Preliminary antifungal activities of three tested compounds at 1 mg/mL.
| Fungi | Average Inhibition Rate ± SD (%) ( | ||
|---|---|---|---|
| BAEO | Benzaldehyde | Kresoxim-Methyl | |
| FOC | 68.3 ± 0.9a | 62.3 ± 0.5b | 67.2 ± 0.9a |
| VM | 50.5 ± 3.0b | 51.4 ± 0.0b | 81.0 ± 1.6a |
| PO | 95.3 ± 0.6a | 54.7 ± 2.3c | 82.2 ± 0.2b |
| FG | 87.0 ± 0.3b | 81.4 ± 0.4c | 93.2 ± 2.3a |
| AA | 80.1 ± 0.2c | 86.7 ± 0.1b | 93.4 ± 0.1a |
| AS | 100.0 ± 0.0 | 100.0 ± 0.0 | 100.0 ± 0.0 |
| PC | 49.2 ± 2.7b | 39.2 ± 0.9c | 85.1 ± 0.4a |
| GF | 91.9 ± 2.0b | 100.0 ± 0.0a | 100.0 ± 0.0a |
| FOL | 49.5 ± 0.8b | 35.5 ± 0.6c | 88.8 ± 0.2a |
| GO | 100.0 ± 0.0 | 100.0 ± 0.0 | 100.0 ± 0.0 |
| VD | 72.5 ± 0.8b | 64.2 ± 0.6c | 82.3 ± 0.1a |
| GG | 100.0 ± 0.0 | 100.0 ± 0.0 | 100.0 ± 0.0 |
| BC | 100.0 ± 0.0a | 100.0 ± 0.0a | 88.8 ± 2.1b |
| FOV | 81.5 ± 0.0 | 40.7 ± 0.0 | 63.0 ± 0.0 |
| CL | 88.7 ± 0.1b | 85.8 ± 0.1c | 94.3 ± 0.0a |
| FOS | 46.7 ± 1.7c | 74.7 ± 0.8b | 81.2 ± 0.5a |
| CG | 44.8 ± 0.6c | 55.8 ± 0.5b | 100.0 ± 0.0a |
| FON | 56.4 ± 0.4c | 83.2 ± 0.2b | 100.0 ± 0.0a |
| AB | 100.0 ± 0.0a | 28.6 ± 0.0c | 83.2 ± 0.8b |
For each row, means followed by different lowercase letters were significantly different, which were calculated by one-way analysis of variance (ANOVA) using Fisher’s least significant difference (LSD) test at a p-value of <0.05. AA, Alternaria alternata (Fr) Keissler; AB, Alternaria brassicae; AS, Alternaria solani; BC, Botrytis cinerea; BG, Blumeria graminis f. sp. tritici; CG, Colletotrichum gloeosporioides (Penz.) et Sacc.; CL, Curvularia lunata; FG, Fusarium graminearum; FOC, Fusarium oxysporum sp. cucumebrium Owen; FOL, Fusarium oxysporum f. sp. lycopersici Synder et Hansen; FON, Fusarium oxysporum f. sp. niveum; FOS, Fusarium oxysporum (Schlecht.); FOV, Fusarium oxysporum f. sp. vasinfectum; GF, Gloeosporium fructigenum; GG, Gaeumannomyces graminis var. tritici; GO, Gloeosporium orbiculare; PC, Phytophthora capsici Leonian; PO, Pyricularia oryzae cavgra; VD, Verticillium dahliae Kleb; VM, Valsa mali Miyabe et Yamade.
Toxicity regression equations for concentration effect and median effective concentration (EC50) values of BAEO against 19 strains of fungi.
| Fungi | Toxicity Regression Equation a | EC50 (μg/mL) | 95% CI of LC50 b | |
|---|---|---|---|---|
| FOC | 0.98 | 511.7 | 451.4–579.9 | |
| VM | 0.93 | 610.8 | 531.4–702.1 | |
| PO | 0.98 | 429.3 | 408.7– 450.9 | |
| FG | 0.97 | 627.9 | 579.0–680.8 | |
| AA | 0.96 | 642.0 | 582.6–707.5 | |
| AS | 0.96 | 103.2 | 73.4–144.9 | |
| PC | 0.92 | 600.5 | 376.0–959.2 | |
| GF | 0.93 | 225.9 | 196.7–259.5 | |
| FOL | 0.92 | 295.1 | 229.1–379.9 | |
| GO | 0.94 | 273.7 | 230.5–325.0 | |
| VD | 0.93 | 325.2 | 0.3082–0.5464 | |
| GG | 0.98 | 192.0 | 104.2–353.7 | |
| BC | 0.99 | 217.0 | 155.2–303.4 | |
| FOV | 0.95 | 526.7 | 491.1–564.8 | |
| CL | 0.97 | 509.5 | 458.2–566.5 | |
| FOS | 0.93 | 423.8 | 363.8–493.8 | |
| CG | 0.98 | 381.8 | 353.9–411.8 | |
| FON | 0.92 | 569.3 | 490.9–660.2 | |
| AB | 0.96 | 50.2 | 42.4–59.3 |
a y, probability of the inhibition; x: log [concentration (mg/mL)]; b 95% CI, lower and upper values of the confidence interval of the 50% lethal concentration (LC50) (mg/mL) at 95% probability.
Toxicity regression equations for concentration effect and EC50 values of kresoxim-methyl against 19 strains of fungi.
| Fungi | Toxicity Regression Equation a | EC50 (μg/mL) | 95% CI of LC50 b | |
|---|---|---|---|---|
| FOC | 0.95 | 10.89 | 8.50–13.97 | |
| VM | 0.96 | 121.20 | 119.54–120.54 | |
| PO | 0.97 | 51.85 | 49.31–52.06 | |
| FG | 0.98 | 2.46 | 1.40–5.59 | |
| AA | 0.95 | 7.737 | 6.28–9.54 | |
| AS | 0.96 | 2.27 | 1.95–2.65 | |
| PC | 0.95 | 0.68 | 0.57–0.85 | |
| GF | 0.95 | 5.87 | 4.60–6.43 | |
| FOL | 0.97 | 0.71 | 0.54–0.93 | |
| GO | 0.96 | 4.60 | 3.96–5.34 | |
| VD | 0.96 | 3.78 | 2.95–4.65 | |
| GG | - | - | 6.26 c | - |
| BC | 0.95 | 132.3 | 129.81–135.30 | |
| FOV | 0.97 | 21.50 | 20.34–25.19 | |
| CL | 0.96 | 76.06 | 74.73–80.36 | |
| FOS | 0.98 | 11.89 | 10.66–13.25 | |
| CG | 0.98 | 15.45 | 14.06–16.98 | |
| FON | 0.97 | 71.40 | 69.81–75.22 | |
| AB | 0.98 | 24.14 | 21.28–27.38 |
a y, probability of the inhibition; x, log [concentration (mg/mL)]; b 95% CI, lower and upper values of the confidence interval of LC50 (mg/mL) at 95% probability; c Reported in [31].
The effect of treatment time on the antifungal activity of BAEO against Fusarium oxysporum f. sp. niveum and Alternaria solani.
| Fungicide | Treatment Time (h) | Inhibition Rate a | |||
|---|---|---|---|---|---|
| FON | AS | ||||
| 0.5 (mg/mL) | 1.0 (mg/mL) | 0.5 (mg/mL) | 1.0 (mg/mL) | ||
| kresoxim-methyl | 24 | 100.00 | 100.00 | 50.00 | 58.33 |
| 48 | 88.62 | 91.56 | 83.03 | 85.17 | |
| 72 | 68.75 | 65.33 | 86.89 | 90.08 | |
| BAEO | 24 | 92.13 | 100.00 | 100.00 | 100.00 |
| 48 | 53.57 | 100.00 | 100.00 | 100.00 | |
| 72 | 33.33 | 100.00 | 100.00 | 100.00 | |
a Inhibition rate calculated from Equation (1) in Section 3.5.
Figure 2Effect of treatment time on the antifungal activity of BAEO against Fusarium oxysporum f. sp. niveum.
Figure 3Effect of treatment time on the antifungal activity of BAEO against Alternaria solani.
Screening the protective effect of BAEO against Gloeosporium orbiculare.
| Concentration (mg/mL) | Disease Index (%) a | Protective Effect (%) b |
|---|---|---|
| 4 | 6.95 | 88.74 |
| 6 | 5.12 | 91.33 |
| 8 | 2.96 | 94.99 |
| 10 | 1.14 | 98.07 |
| 12 | 11.74 | 80.13 |
| Control | 59.07 | - |
a Disease index calculated from Equation (2) in Section 3.6.1; b Protective effect calculated from Equation (3) in Section 3.6.1.
Assay of the therapeutic effect of BAEO against Gloeosporium orbiculare.
| Concentration (mg/mL) | Disease Index (%) a | Therapeutic Effect (%) b |
|---|---|---|
| 4 | 24.45 | 58.61 |
| 6 | 25.94 | 56.09 |
| 8 | 14.36 | 79.09 |
| 10 | 10.65 | 81.97 |
| 12 | 3.89 | 93.41 |
| Control | 59.07 | - |
a Disease index calculated from Equation (2) in Section 3.6.1; b Therapeutic effect calculated from Equation (3) in Section 3.6.1.
Figure 4Disease index of cucumber and wheat seedlings. GO, Gloeosporium orbiculare; BG, Blumeria graminis.
Figure 5Protective and therapeutic efficacy of BAEO against Gloeosporium orbiculare (GO) and Blumeria graminis (BG).
Screening the protective effect of BAEO against Blumeria graminis.
| Concentration (mg/mL) | Disease Index (%) a | Protective Effect (%) b |
|---|---|---|
| 4.0 | 27.38 | 50.99 |
| 6.0 | 25.87 | 53.70 |
| 8.0 | 24.34 | 56.43 |
| 10 | 23.45 | 58.03 |
| 12 | 21.56 | 61.41 |
| Control | 55.87 | - |
a Disease index calculated from Equation (2) in Section 3.6.1; b Protective effect calculated from Equation (3) in Section 3.6.1.
Assay of the therapeutic effect of BAEO against Blumeria graminis.
| Concentration (mg/mL) | Disease Index (%) a | Therapeutic Effect (%) b |
|---|---|---|
| 4.0 | 35.37 | 36.69 |
| 6.0 | 38.89 | 30.39 |
| 8.0 | 39.85 | 28.76 |
| 10 | 31.77 | 43.14 |
| 12 | 27.18 | 51.35 |
| Control | 55.87 | - |
a Disease index calculated from Equation (2) in Section 3.6.1; b Therapeutic effect calculated from Equation (3) in Section 3.6.1.